CHICAGO, June  04, 2026  (GLOBE NEWSWIRE) -- Cosmos Health Inc. (&#34;Cosmos Health&#34; or the &#34;Company&#34;) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its proprietary

COSM

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Cosmos Health expands Sky Premium Life across all 27 EU states via Skroutz

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>CHICAGO, June  04, 2026  (GLOBE NEWSWIRE) -- Cosmos Health Inc. (&amp;#34;Cosmos Health&amp;#34; or the &amp;#34;Company&amp;#34;) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its proprietary</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Cosmos Health announced Sky Premium Life is now shipable across all 27 EU member states via Skroutz, with 96 SKUs available. The cross-border distribution leverages Skroutz&#039;s network to broaden Cosmos&#039;s European footprint and brand visibility, supporting its international growth strategy. The move could lift near-term revenue potential and accelerate Cosmos&#039; global expansion efforts.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Sky Premium Life now shipping across all 27 EU member states via Skroutz.</li><li>96 Sky Premium Life products accessible in EU markets.</li><li>Skroutz enables cross-border distribution, expanding Cosmos&#039; international footprint.</li><li>CEO Greg Siokas calls expansion a milestone for growth.</li><li>Expands Cosmos&#039; global presence in nutraceuticals.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Cosmos Health Inc. (COSM)</strong>: Expansion across 27 EU states via Skroutz could drive revenue growth and international expansion.</li><li><strong>Skroutz (N/A)</strong>: Private e-commerce platform enabling cross-border EU distribution; strategic channel for Cosmos.</li><li><strong>Cana Laboratories S.A. (N/A)</strong>: EU GMP-compliant manufacturing subsidiary supporting expanded European operations.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This is a Corporate Developments update reflecting an international distribution expansion via a strategic partner, reinforcing Cosmos Health&#039;s growth ambitions and global brand-building trajectory in nutraceuticals.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>96 SKUs now accessible across the EU via Skroutz, potential incremental revenue.</li><li>Skroutz cross-border network accelerates Cosmos&#039; EU market penetration.</li><li>No immediate earnings figures provided; monitor guidance and quarterly updates.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>COSM trades on NASDAQ under ticker COSM.</li><li>Sky Premium Life: 96 SKUs expanded to 27 EU states.</li><li>Announcement date: June 4, 2026.</li><li>Skroutz is a leading cross-border e-commerce platform in Europe.</li><li>Cosmos Health brands include Sky Premium Life, Mediterranation, bio-bebe, C-Sept, C-Scrub.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term bullish for COSM as EU distribution expands; revenue impact may materialize in 6–12 months.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>CHICAGO, June  04, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Alnz1zUx-U62knNoYQksGhEcxrr2mZERYGe8YkihbK-a1HdYLZ9yJyDVorokH55-SC4PWsER9GM5dbKEMlI1QtlGNRbLAs--GuqcXIvoz68=" rel="nofollow" target="_blank"><strong><u>Cosmos Health Inc.</u></strong></a><strong> (&#34;Cosmos Health&#34; or the "Company") </strong><a href="https://www.globenewswire.com/Tracker?data=pB5kfNMo_17bu5jzIE9vDDNVb2kXRRL9T1MPXpL2hEIfZya_faQpOfgyuJ15CTRt2Lea-4CSJAu_umXLc3N-oi7QPRLbEtROSGZ6qw0InAs=" rel="nofollow" target="_blank"><strong><u>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/COSM">COSM</a>)</u></strong></a>, a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, Sky Premium Life, is now available for shipment across all 27 European Union Member States through Skroutz, significantly expanding the brand's international reach.</p>  <p>A total of 96 Sky Premium Life products are now accessible to consumers across all 27 European Union Member States through Skroutz, with shipments reaching key markets across Western Europe, Northern Europe, and Central and Eastern Europe. The countries covered include Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, and Sweden.</p>  <p>Skroutz is one of the leading e-commerce platforms in Southeast Europe, connecting millions of consumers with a wide network of merchants and brands. Its cross-border capabilities enable efficient distribution and localized access to products across multiple European markets, making it a strategic channel for international expansion.</p>  <p>The Company believes that this expanded distribution footprint further strengthens the global positioning of the Sky Premium Life brand, enabling broader market penetration and increased accessibility to its portfolio of premium nutraceutical and wellness products.</p>  <p><strong>Greg Siokas, CEO of Cosmos Health, stated: </strong>&#34;The expansion of Sky Premium Life across all 27 EU Member States through Skroutz represents a key milestone in our international growth strategy. By leveraging Skroutz's cross-border infrastructure, we are able to efficiently scale distribution and reach consumers across Europe. This initiative further enhances our brand visibility and supports our continued focus on driving revenue growth and expanding our global presence."</p>  <p><strong>About Cosmos Health Inc.<br></br></strong>Cosmos Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/COSM">COSM</a>), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life&#xAE;, Mediterranation&#xAE;, bio-bebe&#xAE;, C-Sept&#xAE; and C-Scrub&#xAE;. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&amp;D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&amp;D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at <a href="https://www.globenewswire.com/Tracker?data=rEHUz4FxGUvWXwhRrmWyAFmZWeQXH7nUNYB7alu_JVezaVEs24ompY4HdcqIyzIieVZ-Kp9fgO2XXAGVm-h51jiGig8xPDBq4SLAZomz6GzBVQ9T36ODhtga6ufCIoqn" rel="nofollow" target="_blank"><u>www.cosmoshealthinc.com</u></a>, <a href="https://www.globenewswire.com/Tracker?data=fRnysa8yBfLWdmjdPUpCI45ClFP1fcKZqDZTcwFpJjPdQeC1iFvoGA-5JJUx6S18c2VxkWa6oIUN4XvGJYRvJNKjhxn4PsbnNXDpyyrv0cA=" rel="nofollow" target="_blank"><u>www.skypremiumlife.com</u></a>, <a href="https://www.globenewswire.com/Tracker?data=rEHUz4FxGUvWXwhRrmWyAFV1NYoISl-NEY6VHYfAtjE80PQKHpJuauC9L4ygg5DvMV3Xs8c7epQBvzvqpggdPA==" rel="nofollow" target="_blank"><u>www.cana.gr</u></a>, <a href="https://www.globenewswire.com/Tracker?data=GPL5yESqpPPd8gGzhJ-myypxGZ2RPBpEETpMLotZ8rfZg5iV-u9ie1Of1HDpyFgozBhsGH3a4b_z4PT2XmkGlF1Bqp4fDupAufw5IfrzK9A=" rel="nofollow" target="_blank"><u>www.zipdoctor.co</u></a>, <a href="https://www.globenewswire.com/Tracker?data=rEHUz4FxGUvWXwhRrmWyAJd_hJTj3-CVFo5FX9-IpXq1yh4BBM4nT0-hoEoOGNeCl1KDdQdxWeEarY18mGQjPJ1I-jD4bAA3KqWKfIQgmFs=" rel="nofollow" target="_blank"><u>www.cloudscreen.gr</u></a>, as well as <a href="https://www.globenewswire.com/Tracker?data=zYbx1JZhjh0I9giP-TMj2ZGcLFBwe7xxqEaMvkfm7eD81Bw-uM4--zNzWlr4K3pFeINRxV-JdTJ63P42SgezpBMT1Fh9b_1yXpEDI18OEqAG0l2flvXgfV70lk084UIH" rel="nofollow" target="_blank"><u>LinkedIn</u></a> and <a href="https://www.globenewswire.com/Tracker?data=qtVcoy93DVx9obY9z2ZUOp-NJ-QR3HobwaTeCnosDUosjCkpl8CDa4vVrhrjSWOlFy9oJnbeWotyZNvP-n5ZhnzBVeIA_x3ZyEZa8aJQf4M=" rel="nofollow" target="_blank"><u>X</u></a>.</p>  <p align="justify"><strong>Forward-Looking Statements</strong><br></br>With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans," and similar expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could," generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company's control, including, but not limited to: the Company's ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine and ongoing conflicts in the Middle East and other regions on the Company's business, operations, and the economy in general; the Company's ability to successfully develop and commercialize its proprietary products and technologies; changes in interest rates; changes in foreign currency exchange rates, commodity or other price inflation and deflation; our ability to issue debt on terms and at rates acceptable to us; the impact and expected outcome of investigations, inquiries, claims, and litigation; the challenges of operating in international markets; the adequacy of insurance coverage; the effect of accounting charges and of adopting certain accounting standards; the impact of legal and regulatory changes, including changes to tax laws and regulations; guidance for fiscal 2026 and beyond and financial outlook. Forward-looking statements are based on currently available information and our current assumptions, expectations and projections about future events. You should not rely on our forward-looking statements. These statements are not guarantees of future performance and are subject to future events, risks and uncertainties – many of which are beyond our control, dependent on the actions of third parties, or currently unknown to us – as well as potentially inaccurate assumptions that could cause actual results to differ materially from our historical experience and our expectations and projections. These risks and uncertainties include, but are not limited to, those described from time to time in our periodic reports filed with the SEC and available at the SEC's website (<a href="https://www.globenewswire.com/Tracker?data=fRnysa8yBfLWdmjdPUpCI_VnsugsJCV9yapRGQDPQljU_i_bJV66ffM1YYtI5ccXNlHNSncx8Y5yNJuNkHwXVA==" rel="nofollow" target="_blank"><u>www.sec.gov</u></a>). There also may be other factors that we cannot anticipate or that are not described herein, generally because we do not currently perceive them to be material. Such factors could cause results to differ materially from our expectations. Forward-looking statements speak only as of the date they are made, and we do not undertake to update these statements other than as required by law. You are advised, however, to review any further disclosures we make on related subjects in our filings with the Securities and Exchange Commission and in our other public statements.</p>  <p align="justify"><strong>Investor Relations Contact:</strong><br></br>BDG Communications<br></br>cosm@bdgcommunications.com</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTczMjE2MSM3NjM3NTMyIzIyOTgwOTQ="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/YmE3N2JjOWYtNTdhYS00NTYyLWI1NWItOTJjMDhkYjgxOTEyLTEzMDk2NDQtMjAyNi0wNi0wNC1lbg==/tiny/Cosmos-Health-Inc-.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/29681d62-58aa-4ccf-bad9-cb7ce8ae66e4"><img src="https://ml.globenewswire.com/media/29681d62-58aa-4ccf-bad9-cb7ce8ae66e4/small/cosmos-png.png" border="0" width="150" height="78" alt="Primary Logo"></img></a></p>

Cosmos Health announced Sky Premium Life is now shipable across all 27 EU member states via Skroutz, with 96 SKUs available. The cross-border distribution leverages Skroutz's network to broaden Cosmos's European footprint and brand visibility, supporting its international growth strategy. The move could lift near-term revenue potential and accelerate Cosmos' global expansion efforts.

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News